Under construction – not a live service
Sign in
Taking people in FranceNo phase

Studies patient outcomes after heart failure telemonitoring is stopped

Reviews how patients with heart failure fare after leaving a telemonitoring program.

Plain-language title generated from the registry record
Registry title: Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Key facts

Where
Clermont-Ferrand, FranceSee the site

Where in France

  • CHU Clermont-FerrandClermont-Ferrand, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Clermont-Ferrand
Trial code
NCT07278583
Record updated
30 July 2026
Original description
CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.Read full original descriptionShow less

Evaluation of Eligibility Criteria for Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort

CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.

Inclusion: adults; able to read and understand french; included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria.

Exclusion: Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance).

ClinicalTrials.gov NCT07278583